Ponatinib treatment promotes arterial thrombosis and hyperactive platelets.

ABSTRACT:

SUBMITTER: Merkulova A 

PROVIDER: S-EPMC6693004 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature